Top headlines: India FY22 GDP may rise 9.2%; new rules for overseas flyers

Business Standard brings you the top headlines on Friday

Coronavirus, economy, growth
Photo: Bloomberg
BS Web team
2 min read Last Updated : Jan 07 2022 | 6:03 PM IST
India's GDP may grow 9.2% in FY22: First advance estimates

India's economy is expected to grow up to 9.2 per cent in the financial year 2021-22, ending March 2022, as against 7.3% contraction in FY21, according to first advance estimates released by the government on Friday. This is below the 9.5 per cent projection by both RBI and IMF.

"Real GDP or GDP at Constant Prices (2011-12) in the year 2021-22 is estimated at Rs 147.54 lakh crore, as against the Provisional Estimate of GDP for the year 2020-21 of Rs 135.13 lakh crore, released on 31st May 2021. The growth in real GDP during 2021-22 is estimated at 9.2 per cent as compared to the contraction of 7.3 per cent in 2020-21," said MoSPI. Read more

Covid: 7-day home quarantine mandatory for all international arrivals

Amid a surge in the COVID-19 cases, the Central government on Friday announced a seven-day mandatory home quarantine for all international arrivals in the country.

All the international arrivals in the country will have to observe a seven-day mandatory home quarantine with effect from January 11 till further orders. Read more

TCS Board to consider share buyback proposal on Jan 12

India's largest IT firm Tata Consultancy Services (TCS) on Friday said its Board will consider a buyback proposal on January 12.

"...the Board of Directors will consider a proposal for buyback of equity shares of the company, at its meeting to be held on January 12, 2022," a regulatory filing said. Read more

Covid vaccine doses administered in India surpass 1.5 bn-mark

India achieved a major milestone in its vaccination programme against COVID-19 as the cumulative vaccine doses administered in the country surpassed the 150 crore-mark on Friday.

Union Health Minister Mansukh Mandaviya termed it an "historic achievement" made possible because of the relentless hard work of healthcare workers under the able leadership of Prime Minister Narendra Modi. Read more

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusIndia GDP growthGDP growthCoronavirus Vaccine

Next Story